6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Effects of Influenza Vaccination in the United States during the 2017–2018 Influenza Season

      1 , 1 , 1 , 1 , 1 ,   2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 1 , 1 , 1 , The U.S. Flu VE Network, the Influenza Hospitalization Surveillance Network (FluSurv-NET), and the Assessment Branch, Immunization Services Division, Centers for Disease Control and Prevention
      Clinical Infectious Diseases
      Oxford University Press (OUP)

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The severity of the 2017–2018 influenza season in the United States was high, with influenza A(H3N2) viruses predominating. Here, we report influenza vaccine effectiveness (VE) and estimate the number of vaccine-prevented influenza-associated illnesses, medical visits, hospitalizations, and deaths for the 2017–2018 influenza season. We used national age-specific estimates of 2017–2018 influenza vaccine coverage and disease burden. We estimated VE against medically attended reverse-transcription polymerase chain reaction–confirmed influenza virus infection in the ambulatory setting using a test-negative design. We used a compartmental model to estimate numbers of influenza-associated outcomes prevented by vaccination. The VE against outpatient, medically attended, laboratory-confirmed influenza was 38% (95% confidence interval [CI], 31%–43%), including 22% (95% CI, 12%–31%) against influenza A(H3N2), 62% (95% CI, 50%–71%) against influenza A(H1N1)pdm09, and 50% (95% CI, 41%–57%) against influenza B. We estimated that influenza vaccination prevented 7.1 million (95% CrI, 5.4 million–9.3 million) illnesses, 3.7 million (95% CrI, 2.8 million–4.9 million) medical visits, 109 000 (95% CrI, 39 000–231 000) hospitalizations, and 8000 (95% credible interval [CrI], 1100–21 000) deaths. Vaccination prevented 10% of expected hospitalizations overall and 41% among young children (6 months–4 years). Despite 38% VE, influenza vaccination reduced a substantial burden of influenza-associated illness, medical visits, hospitalizations, and deaths in the United States during the 2017–2018 season. Our results demonstrate the benefit of current influenza vaccination and the need for improved vaccines. During the 2017–2018 influenza season, we estimate that influenza vaccination reduced the risk of medically attended influenza by 38% and prevented 7 million illnesses, 4 million medical visits, 109 000 hospitalizations, and 8000 deaths in the United States.

          Related collections

          Author and article information

          Journal
          Clinical Infectious Diseases
          Oxford University Press (OUP)
          1058-4838
          1537-6591
          February 02 2019
          February 02 2019
          Affiliations
          [1 ]Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA
          [2 ]Marshfield Clinical Research Institute, Marshfield, WI
          [3 ]Baylor Scott and White Health, Texas A&M College of Medicine, Temple, TX
          [4 ]University of Pittsburgh Schools of Health Sciences, Pittsburgh, PA
          [5 ]Kaiser Permanente Washington Health Research Institute, Seattle, WA
          [6 ]University of Michigan School of Public Health, Ann Arbor, MI
          [7 ]Colorado Department of Public Health and Environment, Denver, CO
          [8 ]Georgia Emerging Infections Program, Atlanta VA Medical Center, Emory University, Atlanta, GA
          [9 ]University of Rochester School of Medicine and Dentistry, Rochester, NY
          [10 ]Ohio Department of Health, Columbus, OH
          [11 ]Michigan Department of Health and Human Services, Lansing, MI
          [12 ]California Emerging Infections Program, Oakland, CA
          [13 ]Minnesota Department of Health, St. Paul, MN
          [14 ]Maryland Department of Health and Mental Hygiene, Baltimore, MD
          [15 ]Salt Lake County Health Department, Salt Lake City, UT
          [16 ]New York State Emerging Infections Program, New York State Department of Health, Albany, NY
          [17 ]Vanderbilt University, Nashville, TN
          [18 ]Oregon Department of Public Health, Portland, OR
          [19 ]New Mexico Department of Health, Sante Fe, NM
          [20 ]Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT
          [21 ]Immunization Services Division, Centers for Disease Control and Prevention, Atlanta, GA
          Article
          10.1093/cid/ciz075
          7188082
          30715278
          9994b1a3-d9ba-4b32-9f0b-97428c24ad53
          © 2019
          History

          Comments

          Comment on this article